Cover Image

The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo

Vorinostat (SAHA) is a histone deacetylase inhibitor that exerts its effects through epigenetic regulation. Specifically, SAHA can inhibit the proliferation of triple-negative breast cancer (TNBC) cells alone or in combination with other chemotherapeutic agents. Doxorubicin (DOX), a traditional chem...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuheng Pang (Author), Runze Shi (Author), Liujia Chan (Author), Yu Lu (Author), Di Zhu (Author), Tong Liu (Author), Meisi Yan (Author), Yuji Wang (Author), Wenjing Wang (Author)
Format:	Book
Published:	Elsevier, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phosphorus containing analogues of SAHA as inhibitors of HDACs
by: Michael D. Pun, et al.
Published: (2022)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022)

Inhibition of HDAC3- and HDAC6-promoted survivin expression plays an important role in SAHA-induced autophagy and viability reduction in breast cancer cells
by: Jane Ying-Chieh Lee, et al.
Published: (2016)

Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells
by: Liujia Chan, et al.
Published: (2022)

Professor Kshitish Chandra Saha
by: Arijit Coondoo
Published: (2016)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
by: Dominick Salerno, et al.
Published: (2021)

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment
by: Wu Zhong, et al.
Published: (2023)

Oncolytic viruses for triple negative breast cancer and beyond
by: Shengye Jin, et al.
Published: (2021)

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
by: Wardhani BWK, et al.
Published: (2020)

Understanding doxorubicin associated calcium remodeling during triple-negative breast cancer treatment: an in silico study
by: Garhima Arora, et al.
Published: (2021)

Futbolda farklı saha zeminlerinin kas hasarı üzerine etkisi
by: Aydin Karabulak, et al.
Published: (2023)

Donor-to-donor variation in the host gene expression response to SAHA
by: B. Moesker, et al.
Published: (2015)

War and pandemic: a negative synergism could amplify the catastrophe
by: Mauro Giovanni Carta, et al.
Published: (2022)

Synthesis, Characterization, and In Vitro Cytotoxicity Evaluation of Doxorubicin-Loaded Magnetite Nanoparticles on Triple-Negative Breast Cancer Cell Lines
by: Jano Markhulia, et al.
Published: (2023)

Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer
by: Azam Saghaeidehkordi, et al.
Published: (2021)

Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis
by: Huilin Liu, et al.
Published: (2021)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021)

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
by: Gamal-Eldein Fat, et al.
Published: (2020)

CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells
by: Dnyaneshwar Kalyane, et al.
Published: (2022)

Pharmacological interactions: Synergism, or not synergism, that is the question
by: Luigino Calzetta, et al.
Published: (2021)

Role of flavonoids in inhibiting triple-negative breast cancer
by: Shuai Wang, et al.
Published: (2024)

Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]
by: Gamal Eldein Fathy Abd-ellatef, et al.
Published: (2023)

ICI 182,780 has agonistic effects and synergizes with estradiol-17 beta in fish liver, but not in testis
by: Power Deborah M, et al.
Published: (2006)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014)

Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice
by: Nigel Bush, et al.
Published: (2020)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Hossein Dargahi, et al.
Published: (2012)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Curus Azimi, et al.
Published: (2012)

Iron Complexation to Histone Deacetylase Inhibitors SAHA and LAQ824 in PEGylated Liposomes Can Considerably Improve Pharmacokinetics in Rats
by: Yan Wang, et al.
Published: (2015)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020)

The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis
by: Ignacio Silva-Llanes, et al.
Published: (2023)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023)

Improving the realibility of zinc oxide surge arrester / Azrina Abd Aziz and Tapan K. Saha
by: Abd Aziz, Azrina, et al.
Published: (2006)

HDAC5-Mediated Acetylation of p100 Suppresses Its Processing
by: Jianqi Wang, et al.
Published: (2023)

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
by: Bo Zhou, et al.
Published: (2019)

Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023)

Brain Metastasis in Triple-Negative Breast Cancer
by: Eduarda Bustamante, et al.
Published: (2024)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021)

EFFECT OF SAHA AND C-JUN N-TERMINAL KINASE INHIBITOR ON THE INDUCIBLE MRNA EXPRESSION OF INTERLEUKIN-17
by: Boncho Grigorov, et al.
Published: (2023)